Literature DB >> 7904529

Noradrenergic modulation of gamma-aminobutyric acid outflow from the human cerebral cortex.

L Ferraro1, S Tanganelli, G Caló, T Antonelli, A Fabrizi, N Acciarri, C Bianchi, L Beani, M Simonato.   

Abstract

The noradrenergic modulation of endogenous gamma-aminobutyric acid (GABA) outflow from slices and synaptosomes prepared from human cerebral cortex biopsies has been studied. GABA outflow was responsive to depolarizing stimuli such as ouabain and high potassium. Basal GABA outflow in slices, but not in synaptosomes, appeared to be largely dependent upon neuronal activity, being prevented by tetrodotoxin (TTX). 10 mM K(+)-evoked outflow in synaptosomes also proved to be TTX sensitive. Norepinephrine (NE) concentration dependently increased basal GABA outflow both in slices and synaptosomes. This effect was alpha 1-adrenoreceptor-mediated because it was prevented by a selective antagonist of the alpha 1-adrenoreceptor class (prazosin) but not by the alpha 2 antagonist idazoxan. However, an alpha 2-mediated inhibitory modulation was also present in the preparations used, since (1) in slices, NE significantly inhibited GABA outflow in the presence of prazosin; (2) in synaptosomes, NE significantly inhibited 10 mM K(+)-evoked outflow in the presence of prazosin. Both of these effects were prevented by idazoxan. No beta-adrenoreceptor modulation could be demonstrated. A comparison between species was also conducted. The response to ouabain and to TTX proved similar in human, rat and guinea-pig cerebral cortex. In the most simple tissue preparation used (synaptosomes), a close similarity between the three species could be observed. In all species, NE stimulated basal GABA outflow, an effect prevented by prazosin. This suggests a predominant alpha 1-adrenoreceptor-mediated stimulatory effect. In a more complex preparation (slices), differences between species could be demonstrated.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7904529     DOI: 10.1016/0006-8993(93)90487-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

1.  Evidence for an in vivo and in vitro modulation of endogenous cortical GABA release by alpha-glycerylphosphorylcholine.

Authors:  L Ferraro; S Tanganelli; L Marani; C Bianchi; L Beani; A Siniscalchi
Journal:  Neurochem Res       Date:  1996-05       Impact factor: 3.996

2.  Nicotinic receptor activation in human cerebral cortical interneurons: a mechanism for inhibition and disinhibition of neuronal networks.

Authors:  M Alkondon; E F Pereira; H M Eisenberg; E X Albuquerque
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

3.  Changes in [3H]-UK 14304 binding to alpha 2-adrenoceptors in morphine-dependent guinea-pigs.

Authors:  K Varani; L Beani; C Bianchi; P A Borea; M Simonato
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

Review 4.  Mechanisms of action of antidepressants: from neurotransmitter systems to signaling pathways.

Authors:  Chirisse Taylor; Ashwana D Fricker; Lakshmi A Devi; Ivone Gomes
Journal:  Cell Signal       Date:  2005-05       Impact factor: 4.315

5.  5-Hydroxytryptamine-mediated effects of nicotine on endogenous GABA efflux from guinea-pig cortical slices.

Authors:  C Bianchi; L Ferraro; S Tanganelli; M Morari; G Spalluto; M Simonato; L Beani
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

6.  Chromatin remodeller CHD7 is required for GABAergic neuron development by promoting PAQR3 expression.

Authors:  Priyanka Jamadagni; Maximilian Breuer; Kathrin Schmeisser; Tatiana Cardinal; Betelhem Kassa; J Alex Parker; Nicolas Pilon; Eric Samarut; Shunmoogum A Patten
Journal:  EMBO Rep       Date:  2021-04-26       Impact factor: 8.807

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.